Mayo Clinic | Strategic Alliance Partners

Latest from Mayo Clinic


Dr. Palmer on Molecular Abnormalities in Myeloproliferative Diseases

April 16, 2018

Jeanne M. Palmer, MD, hematologist oncologist, Mayo Clinic, discusses molecular abnormalities in myeloproliferative diseases, including polycythemia vera (PV) and the use of next-generation sequencing in identifying these mutations.

Dr. Stewart on the Role of Transplant in Multiple Myeloma

April 13, 2018

Keith Stewart, MB, CHB, professor of medicine, consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, discusses the role of transplant in patients with multiple myeloma.